Under the Seventh Community Pharmacy Agreement (7CPA), the Australian Government has committed indicative funding of $105.5 million to the Medication Adherence Community Pharmacy Programs during the first year of the 7CPA, which includes the Dose Administration Aid (DAA) and Staged Supply Programs.

The new Indigenous Dose Administration Aids (IDAA) Program has been designed to assist patients in the community who identify as Aboriginal and/or Torres Strait Islander to better manage their medicines, with the objective of avoiding medication misadventure and improving medication adherence.
The IDAA Program will closely mirror, and run parallel with, the broader DAA Program with a few key differences, including:

• A payment of $11.60 per DAA with no additional patient charge to be applied;
• Patient eligibility criteria to support Aboriginal and/or Torres Strait Islander patients;
• Access to the Program will be uncapped, unlike the broader DAA Program, which has weekly service caps applied to individual pharmacies.

Services provided under the IDAA Program will not contribute to the weekly cap on services undertaken via the main DAA Program. However, expenditure on the IDAA and DAA Programs will be monitored.

For more information regarding the IDAA Program, please click here.